National Asset Management, Inc. Eli Lilly & CO Transaction History

National Asset Management, Inc.

$3.51 Billion
Q3 2024

A detailed history of National Asset Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, National Asset Management, Inc. holds 37,307 shares of LLY stock, worth $29.7 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

37,307

Previous 38,230 2.41%

Holding current value

$29.7 Million

Previous $34.6 Million 4.51%

% of portfolio

0.94%

Previous 0.91%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 13, 2024	SELL	$772.14 - $960.02 $712,685 - $886,098	-923 Reduced 2.41%	37,307 $33.1 Million
Q2 2024 Aug 19, 2024	SELL	$724.87 - $909.04 $3.51 Million - $4.41 Million	-4,848 Reduced 11.25%	38,230 $34.6 Million
Q1 2024 May 16, 2024	BUY	$592.2 - $792.28 $1.76 Million - $2.36 Million	2,973 Added 7.41%	43,078 $33.5 Million
Q4 2023 Mar 15, 2024	SELL	$525.19 - $619.13 $1.56 Million - $1.84 Million	-2,973 Reduced 6.9%	40,105 $23.4 Million
Q3 2023 Dec 01, 2023	BUY	$434.7 - $599.3 $406,879 - $560,944	936 Added 2.22%	43,078 $23.1 Million
Q2 2023 Jul 27, 2023	SELL	$350.74 - $468.98 $1.25 Million - $1.67 Million	-3,558 Reduced 7.79%	42,142 $19.8 Million
Q1 2023 May 17, 2023	BUY	$310.63 - $364.82 $1.87 Million - $2.2 Million	6,027 Added 15.19%	45,700 $15.7 Million
Q4 2022 Mar 15, 2023	SELL	$321.55 - $374.67 $379,750 - $442,485	-1,181 Reduced 2.89%	39,673 $14.5 Million
Q4 2022 Feb 21, 2023	BUY	$321.55 - $374.67 $1.69 Million - $1.97 Million	5,264 Added 14.79%	40,854 $14.9 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $3.91 Million - $4.46 Million	13,203 Added 58.98%	35,590 $11.5 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $395,517 - $464,396	1,419 Added 6.77%	22,387 $7.26 Million
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $594,235 - $738,483	-2,532 Reduced 10.77%	20,968 $6.01 Million
Q4 2021 Jan 28, 2022	BUY	$224.85 - $279.04 $91,064 - $113,011	405 Added 1.75%	23,500 $6.49 Million
Q3 2021 Nov 16, 2021	SELL	$221.6 - $272.71 $52,962 - $65,177	-239 Reduced 1.02%	23,095 $5.34 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $2.3 Million - $2.98 Million	-12,758 Reduced 35.35%	23,334 $5.34 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $3.07 Million - $3.97 Million	18,676 Added 107.23%	36,092 $6.74 Million
Q4 2020 Feb 04, 2021	SELL	$130.46 - $172.63 $1.44 Million - $1.9 Million	-11,030 Reduced 38.78%	17,416 $2.94 Million
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $1.93 Million - $2.23 Million	13,196 Added 86.53%	28,446 $4.39 Million
Q2 2020 Jul 31, 2020	SELL	$136.42 - $164.18 $117,457 - $141,358	-861 Reduced 5.34%	15,250 $2.5 Million
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $46,905 - $58,055	-394 Reduced 2.39%	16,111 $2.24 Million
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $243,243 - $301,278	2,275 Added 15.99%	16,505 $2.17 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $149,292 - $162,391	1,398 Added 10.89%	14,230 $1.59 Million
Q2 2019 Aug 05, 2019	SELL	$110.79 - $129.32 $64,812 - $75,652	-585 Reduced 4.36%	12,832 $1.43 Million
Q1 2019 May 08, 2019	BUY	$111.31 - $131.02 $19,145 - $22,535	172 Added 1.3%	13,417 $1.74 Million
Q4 2018 Feb 08, 2019	BUY	$105.9 - $118.64 $160,650 - $179,976	1,517 Added 12.93%	13,245 $1.53 Million
Q3 2018 Nov 08, 2018	SELL	$85.86 - $107.31 $30,909 - $38,631	-360 Reduced 2.98%	11,728 $1.26 Million
Q2 2018 Oct 05, 2018	BUY	$75.7 - $86.88 $1,816 - $2,085	24 Added 0.2%	12,088 $1.03 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $803,323 - $948,269	-10,825 Reduced 47.29%	12,064 $935,000
Q4 2017 Feb 15, 2018	SELL	$81.94 - $87.89 $96,771 - $103,798	-1,181 Reduced 4.91%	22,889 $1.94 Million
Q3 2017 Nov 13, 2017	SELL	$77.07 - $85.54 $37,764 - $41,914	-490 Reduced 2.0%	24,070 $2.06 Million
Q2 2017 Aug 15, 2017	BUY	N/A	24,560	24,560 $2.02 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.

Account

National Asset Management, Inc. Eli Lilly & CO Transaction History